Ning‐Chi Wang
Impact in
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- Antifungal resistance and susceptibility
- Endocrinology top 5%
- Infections and bacterial resistance
Papers in
-
- HIV/AIDS drug development and treatment 7
- Antifungal resistance and susceptibility 4
- Antimicrobial Resistance in Staphylococcus 3
- Epidemiology 19
- Cytomegalovirus and herpesvirus research 4
- Co-authors
- Feng‐Yee Chang (19 shared papers)Jung‐Chung Lin (13 shared papers)Ming-Yieh Peng (7 shared papers)Te‐Yu Lin (21 shared papers)Sheng-Kang Chiu (5 shared papers)Ya‐Sung Yang (7 shared papers)Oliver Yoa‐Pu Hu (2 shared papers)Kuo‐Ming Yeh (6 shared papers)
In The Last Decade
Ning‐Chi Wang
62 papers receiving 1.2k citations
Ning‐Chi Wang's Hit Papers
Peers
Comparison fields: 5 of 78
- Infectious Diseases 558
- Endocrinology 58
- Molecular Medicine 82
- Hepatology 94
- Pharmacology 88
Countries citing papers authored by Ning‐Chi Wang
This map shows the geographic impact of Ning‐Chi Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning‐Chi Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning‐Chi Wang more than expected).
Fields of papers citing papers by Ning‐Chi Wang
This network shows the impact of papers produced by Ning‐Chi Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning‐Chi Wang. The network helps show where Ning‐Chi Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning‐Chi Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 66 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials Hit paper breakdown → | 2018 | 313 |
| 2 | 2013 | 86 | |
| 3 | 2014 | 45 | |
| 4 | 2010 | 39 | |
| 5 | 2017 | 37 | |
| 6 | Acute acalculous cholecystitis and pancreatitis in a patient with concomitant leptospirosis and scrub typhus. | 2003 | 34 |
| 7 | 2008 | 34 | |
| 8 | Cryptococcal disease in patients with or without human immunodeficiency virus: clinical presentation and monitoring of serum cryptococcal antigen titers. | 2009 | 34 |
| 9 | 2014 | 34 | |
| 10 | Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis. | 2008 | 33 |
| 11 | Necrotizing fasciitis in a medical center in northern Taiwan: emergence of methicillin-resistant Staphylococcus aureus in the community. | 2007 | 32 |
| 12 | 2015 | 30 | |
| 13 | Impact of underlying diseases on the clinical characteristics and outcome of primary pyomyositis. | 2008 | 29 |
| 14 | 2012 | 26 | |
| 15 | 2013 | 26 | |
| 16 | 2017 | 25 | |
| 17 | 2018 | 23 | |
| 18 | 2017 | 21 | |
| 19 | 2013 | 19 | |
| 20 | 2018 | 19 |
About Ning‐Chi Wang
Ning‐Chi Wang is a scholar working on Infectious Diseases, Epidemiology, Hepatology, Molecular Medicine and Endocrinology, having authored 66 papers that have together received 1.3k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (7 papers), Antifungal resistance and susceptibility (4 papers), Cytomegalovirus and herpesvirus research (4 papers), Antibiotic Resistance in Bacteria (4 papers), Hepatitis C virus research (3 papers), HIV Research and Treatment (3 papers), Antimicrobial Resistance in Staphylococcus (3 papers) and Hepatitis Viruses Studies and Epidemiology (3 papers). The work is most often cited by research in Infectious Diseases (558 citations), Endocrinology (58 citations), Molecular Medicine (82 citations), Hepatology (94 citations) and Pharmacology (88 citations). Ning‐Chi Wang has collaborated with scholars based in Taiwan, Japan and China. Frequent co-authors include Feng‐Yee Chang, Jung‐Chung Lin, Ming-Yieh Peng, Te‐Yu Lin, Sheng-Kang Chiu, Ya‐Sung Yang, Oliver Yoa‐Pu Hu, Kuo‐Ming Yeh, Wen-Liang Chang and Chien‐Ching Hung. Their work appears in journals such as Journal of Microbiology Immunology and Infection, The American Journal of the Medical Sciences, PLoS ONE, Vaccine and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.